Fig. 6: Copy number variations of genes in the TARGET OS dataset.
From: Frequent copy number gain of MCL1 is a therapeutic target for osteosarcoma
Copy number variations of MYC (gain 63, loss 1), MCL1 (gain 57, loss 1), IGF1R (gain 47, loss 15), PDGFRA (gain 45, loss 3), MDM2 (gain 34, loss 12), BCL2L1 (gain 32, loss 9), PTEN (gain 8, loss 39), RB1 (gain 6, loss 48), and TP53 (gain 9, loss 50) genes in 81 pediatric patients with osteosarcoma in the TARGER dataset.
